Open AccessEculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis
Author(s) -
Jon Jin Kim,
Simon Waller,
Christopher Reid
Publication year - 2012
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 40
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ckj/sfr174
Subject(s) - eculizumab , atypical hemolytic uremic syndrome , complement system , medicine , dialysis , alternative complement pathway , complement component 5 , haemolytic uraemic syndrome , complement (music) , immunology , classical complement pathway , monoclonal , monoclonal antibody , complement factor b , disease , antibody , biology , genetics , escherichia coli , complementation , gene , phenotype
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom